Delcath Systems Secures Up to a $20.0 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.GlobeNewsWire • 08/09/21
Delcath Systems Schedules Conference Call to Report 2021 Second Quarter Financial ResultsGlobeNewsWire • 07/28/21
Delcath Systems to Present at Access to Giving Virtual Conference on July 13, 2021 at 3 p.m. ETGlobeNewsWire • 07/07/21
Delcath Systems' Hepzato Achieves 44% Best Overall Response Compared to Best Alternative Care in Eye CancerBenzinga • 06/07/21
Positive Preliminary Results from Delcath Systems' FOCUS Trial Presented at the 2021 ASCO Annual MeetingGlobeNewsWire • 06/07/21
Delcath Systems to Present at LD Micro Virtual Investor Conference on June 10, 2021, at 2:30pm ETGlobeNewsWire • 06/03/21
Delcath Systems, Inc. (DCTH) CEO Gerard Michel on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/11/21
Delcath Systems, Inc. (DCTH) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/11/21
Delcath Systems Schedules Conference Call to Report 2021 First Quarter Financial ResultsGlobeNewsWire • 04/30/21
Delcath Systems Announces Oral Presentation at the American Society of Clinical Oncology (ASCO) Annual MeetingGlobeNewsWire • 04/30/21
Delcath Systems, Inc. Announces Revised NICE Guidance for CHEMOSAT in the United KingdomGlobeNewsWire • 04/21/21
Delcath Systems, Inc. Shares Additional Information Regarding FOCUS Trial Power CalculationGlobeNewsWire • 03/31/21
Delcath Systems, Inc. (DCTH) CEO Gerard Michel on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/31/21
Delcath Stock Moves Higher After Hepzato Achieves ORR Of 29.2% Beating Prespecified Threshold In Eye Cancer StudyBenzinga • 03/31/21
Delcath Systems, Inc. Announces Fourth Quarter 2020 Results, Highlights Preliminary Positive FOCUS Trial Results; Conference Call Today at 8:00am Eastern TimeGlobeNewsWire • 03/31/21